Combining Empagliflozin and Linagliptin with Metformin Reduces HbA1c in Patients with T2DM

Article Information

DOI 
http://dx.doi.org/10.1177/155989771432005
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 MD Conference Express®

Author Information

  1. Nicola Parry
  1. Ralph A. DeFronzo, MD
    1. University of Texas Health Science Center, San Antonio, Texas, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
May 2015702
Jun 2015111
Jul 2015211
Aug 2015500
Oct 2015232
Nov 2015200
Total2456

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Combining Empagliflozin and Linagliptin with Metformin Reduces HbA1c in Patients with T2DM
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Hyperglycemia/Hypoglycemia
Diabetes & Endocrinology Clinical Trials
Diabetes Mellitus
Hyperglycemia/Hypoglycemia
Endocrinology
Diabetes & Metabolic Syndrome
Diabetes & Endocrinology Clinical Trials
Diabetes Mellitus